Silexion Therapeutics Corp (SLXN)

Finanzdaten der Silexion Therapeutics Corp-Aktie (SLXN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	33.87%3.68	2.75	4.41	3.29	2.28
Research and Development	61.46%2.21	1.37	3.38	2.16	1.02
Operating Income/Loss	33.87%-3.68	-2.75	-4.41	-3.29	-2.28
	706.25%-0.13	-0.02	0.01	-0.03	0.22
Interest And Devidend Income	56.25%0.01	0.03	0.07	0.04	0.04
Income/Loss From Continuing Operations Before Tax	29.93%-3.55	-2.73	-4.41	-3.26	-2.50
	29.93%-3.55	-2.73	-4.41	-3.26	-2.50
Attributable To Parent	29.93%-3.55	-2.73	-4.41	-3.26	-2.50
Basic Average Shares	78.72%0.69	3.23	-	1.13	0.58
Diluted Average Shares	78.72%0.69	3.23	-	1.13	0.58
Basic Earnings Per Share	508.24%5.17	0.85	-	2.88	4.32
Diluted Earnings Per Share	508.24%5.17	0.85	-	2.88	4.32